Border disease Virus E2 antibody and antigen (recombinant protein)
Diagnostic anti-Border disease Virus E2 antibodies pairs and antigen for animal health (animal Ovines/Sheep, Caprine/Goat infectious disease ) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT
Go to Border disease Virus infection diagnostics products collection
>>
Product information
Size: 1mg | 10mg | 100mg
Catalog No. | Description | US $ Price (per mg) | First Order Discount | First Order Discount Price |
---|---|---|---|---|
GMP-VT-P085-Tg001-Ag01 | Recombinant Border disease Virus E2 protein | 3090 | ||
GMP-VT-P085-Tg001-Ab01 | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-VT-P085-Tg001-Ab02 | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-VT-P085-Tg001-Ab03 | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
GMP-VT-P085-Tg001-Ab04 | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) | 1953 | 20% | 1562.4 |
Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)
Product Description
Cat No. of Products | GMP-VT-P085-Tg001-Ag01 |
Product Name | Recombinant Border disease Virus E2 protein |
Pathogen | Border Disease Virus |
Target/Biomarker | E2 |
Expression platform | E.coli |
Isotypes | Recombinant Antigen |
Bioactivity validation | Anti-Border Disease Virus E2 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Border Disease Virus level test of animal Ovines/Sheep, Caprine/Goat with Border disease Virus infection. |
Tag | His |
Products description | Recombinant Border disease Virus E2 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Cat No. of Products | GMP-VT-P085-Tg001-Ab01, GMP-VT-P085-Tg001-Ab02, GMP-VT-P085-Tg001-Ab03, GMP-VT-P085-Tg001-Ab04 |
Product Name | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) |
Pathogen | Border Disease Virus |
Target/Biomarker | E2 |
Expression platform | CHO |
Isotypes | Mouse IgG |
Bioactivity validation | Recombinant Border Disease Virus E2 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Border Disease Virus antibodies in Border Disease Virus level test of animal Ovines/Sheep, Caprine/Goat with Border disease Virus infection. |
Tag | mFc |
Products description | Anti-Border disease Virus E2 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair. |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Target/Biomarker information
Border disease (BD) is a viral disease of sheep and goats, primarily causing congenital diseases, but can also cause acute and persistent infections. It first appeared in the border regions of England and Wales in 1959, and has since spread world-wide.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.
Comments
No comments yet.